Pfizer’s recent decision to withdraw its sickle cell pill, Oxbryta, from the market due to safety concerns has sent shockwaves through the sickle cell community. The move comes after studies…
Subscribe Now for Real-time Updates on the Latest Stories!
Credit: Pixabay/CC0 Public Domain As life expectancy continues to rise, the focus on safe and effective lifestyle interventions for healthy…
Sign in to your account